Click Here For
WiredPatrol Site
"You Are a Child of the Universe, No Less than the Trees or the Stars"
 RETURN TO MESSAGES INDEX  

strangely enough but back in 1999 Prucalopride was a treatment for CONSTIPATION

September 13 2007 at 1:28 PM
 


Response to researchers tested prucalopride ...as a NEW CLASS of ANTIDEPRESSANT

Gut 1999;44:682-686 ( May )

Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans

E P Bouras, M Camilleri, D D Burton, S McKinzie

Gastroenterology Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

Correspondence to: Dr M Camilleri, Mayo Clinic, GI Unit---Alfred 2-435, 200 First St SW, Rochester, MN 55905, USA.

Accepted for publication 6 January 1999

BACKGROUND---Prucalopride (R093877) is a selective and specific 5HT4 agonist, the first of a new chemical class of benzofurans, with gastrointestinal prokinetic activities in vitro.
AIMS---To evaluate the effects of prucalopride on gastrointestinal and colonic transit.
METHODS---A validated scintigraphic technique was used to measure gastrointestinal and colonic transit over 48 hours in 50 healthy volunteers. For seven days, each subject received a daily dose of 0.5, 1, 2, or 4 mg prucalopride, or placebo in a double blind, randomised fashion. The transit test was performed over the last 48 hours.
RESULTS---There were significant accelerations of overall colonic transit at 4, 8, 24, and 48 hours (p<0.05) and proximal colonic emptying t1/2 (p<0.05). The 0.5, 2, and 4 mg doses of prucalopride were almost equally effective and accelerated colonic transit compared with placebo. Prucalopride did not significantly alter gastric emptying (p>0.5) or small bowel transit (overall p=0.12). The medication appeared to be well tolerated during the seven day treatment of healthy subjects.
CONCLUSION---Prucalopride accelerates colonic transit, partly by stimulating proximal colonic emptying, but does not alter gastric or small bowel transit in healthy human subjects. Prucalopride deserves further study in patients with constipation.
(Gut 1999;44:682-686)

Keywords: benzofuran;  prucalopride;  motility;  transit;  colon;  gastrointestinal


© 1999 by Gut



 
 Respond to this message   
Responses

  1. Treatment of Irritable Bowel Syndrome and Functional Constipation: New Insights - morse on Sep 13, 1:31 PM
    1. US patent for Prucalopride oral solution - morse on Sep 13, 1:34 PM
      1. Prucalopride is generically described in EP-0,445,862-A1, published on Sep. 11, 1991, .... - errrr it's 2007 now on Sep 13, 1:36 PM
     


Visit RxISK ORG from Data Based Medicine
'the first free website (not sponsored by big pharma or advertising) for patients
and their doctors to research, and more importantly, easily report drug side effects'.